SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 607 filers reported holding SEAGEN INC in Q3 2023. The put-call ratio across all filers is 3.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,981,345 | +17.5% | 9,331 | +6.7% | 0.00% | +50.0% |
| Q2 2023 | $1,686,051 | -5.1% | 8,741 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $1,777,133 | +60.8% | 8,741 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $1,104,950 | -3.8% | 8,741 | +4.4% | 0.00% | 0.0% |
| Q3 2022 | $1,149,000 | -22.7% | 8,373 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,487,000 | +46.1% | 8,373 | +16.9% | 0.00% | +100.0% |
| Q1 2022 | $1,018,000 | -9.9% | 7,161 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,130,000 | -5.1% | 7,161 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $1,191,000 | +5.3% | 7,161 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,131,000 | +37.6% | 7,161 | +20.8% | 0.00% | +100.0% |
| Q1 2021 | $822,000 | -24.9% | 5,930 | -5.2% | 0.00% | -50.0% |
| Q4 2020 | $1,095,000 | – | 6,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |